Delivery Order SPE2DB22D9143-SPE2DB24FZC00

Award Date 5/9/24
Potential Completion Date 5/31/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4566087887 MIRENA 52 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group that runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The contract has a completion date of February 13, 2024 and a potential value of $2,960.00. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of medical supplies and pharmaceuticals to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,920.00 contract is for the delivery of 4566488873 MIRENA 52 MG SYSTEMS and has a period of performance through December 6, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with a period of performance through April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB20D9354 with the DLA, which has a ceiling value of up...
The Defense Logistics Agency (DLA) awarded a $59,200.00 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Mirena 52 mg systems. The contract, which has a completion date of January 31, 2024, is not associated with a larger contract vehicle. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic prescription and over-the-counter drug supplies to the federal government,...
The U.S. Defense Logistics Agency (DLA) awarded a $11,840.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems and has a completion date of May 29, 2024. This award is under a larger single-award indefinite delivery contract (IDC) vehicle between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract has a ceiling value of $15,623.10 and a period of performance through February 4, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Mirena 52 mg systems. The contract has a potential value of $3,552.00 and a completion date of January 30, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products in support of military treatment facilities...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,129.72 contract is for the delivery of MIRENA 52 MG SYSTEMS. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables DLA to issue firm fixed-price...
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract, valued at $11,840.00, has an ultimate completion date of September 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to $499,999,999, which runs through...
  • SPE2DB22D9143
    Indefinite Delivery Contract
  • SPE2DB22D9143-SPE2DB24FZC00
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The $11,840.00 firm fixed-price contract has a period of performance through May 31, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA to issue orders for a comprehensive range of pharmaceutical items to support military medical facilities worldwide. DMS Pharmaceutical Group specializes in supplying branded and generic prescription drugs, over-the-counter medications, biologics, and other medical supplies to the Department of Defense and Department of Veterans Affairs.

Generated 8/8/24, 9:13 AM